Commentary reveals critical peptide surveillance gaps in donor screening, indicating that advanced diagnostic tools could enhance patient safety.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Parisi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: